Evidence map›Paper›PMID 35680879›Full record

ArticleNature communications2022

Norepinephrine potentiates and serotonin depresses visual cortical responses by transforming eligibility traces.

Su Z Hong, Lukas Mesik, Cooper D Grossman, Jeremiah Y Cohen, Boram Lee, Daniel Severin, Hey-Kyoung Lee, Johannes W Hell, Alfredo Kirkwood

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Adaptive control of synaptic plasticity integrates micro- and macroscopic network function.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Su Z HongMind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.
Lukas MesikMind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.
Cooper D GrossmanDepartment of Neuroscience, Johns Hopkins University, Baltimore, MD, 21205, USA.ORCID http://orcid.org/0000-0002-2548-9784
Jeremiah Y CohenDepartment of Neuroscience, Johns Hopkins University, Baltimore, MD, 21205, USA.ORCID http://orcid.org/0000-0002-4768-7124
Boram LeeDepartment of Pharmacology, University of California at Davis, Davis, CA, 95616, USA.
Daniel SeverinMind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.
Hey-Kyoung LeeMind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.ORCID http://orcid.org/0000-0002-5554-983X
Johannes W HellDepartment of Pharmacology, University of California at Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0001-7960-7531
Alfredo KirkwoodMind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA. Kirkwood@jhu.edu.ORCID http://orcid.org/0000-0001-9148-9742
Johns Hopkins University · USUniversity of California, Davis · US

Funding

Global Synpatic Plasticity Mechanisms in Visual CortexR01EY014882 · NEI · UNIV OF MARYLAND, COLLEGE PARK · PI Hey-Kyoung Lee · 2004 to 2026
$7.9M
Regulation of Synaptic Plastiticy in Visual CortexR01EY012124 · NEI · JOHNS HOPKINS UNIVERSITY · PI KIRKWOOD, ALFREDO · 1998 to 2021
$7.6M
Role of a-actinin in Cav1.2 FunctionR01AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2016 to 2026
$4.0M
Reversible activation on critical plasticity in visual cortexR01EY025922 · NEI · UNIV OF MARYLAND, COLLEGE PARK · PI KIRKWOOD, ALFREDO, MURASE, SACHIKO · 2015 to 2024
$3.6M
Molecular Mechanisms of Postsynaptic AMPA Receptor LocalizationR01MH097887 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2014 to 2018
$2.5M
Postsynaptic Signaling by Norepinephrine and cAMPR01NS123050 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2022 to 2026
$2.3M
Functions of identified dorsal raphe neurons during motivated behaviorR01DA042038 · NIDA · JOHNS HOPKINS UNIVERSITY · PI COHEN, JEREMIAH YAACOV · 2016 to 2020
$1.6M
NEI NIH HHS R01 EY012124NEI NIH HHS R01 EY014882NEI NIH HHS R01 EY025922NIA NIH HHS R01 AG055357NIDA NIH HHS R01 DA042038NIMH NIH HHS R01 MH097887NINDS NIH HHS R01 NS123050
6 · The paper itself

Abstract

Reinforcement allows organisms to learn which stimuli predict subsequent biological relevance. Hebbian mechanisms of synaptic plasticity are insufficient to account for reinforced learning because neuromodulators signaling biological relevance are delayed with respect to the neural activity associated with the stimulus. A theoretical solution is the concept of eligibility traces (eTraces), silent synaptic processes elicited by activity which upon arrival of a neuromodulator are converted into a lasting change in synaptic strength. Previously we demonstrated in visual cortical slices the Hebbian induction of eTraces and their conversion into LTP and LTD by the retroactive action of norepinephrine and serotonin Here we show in vivo in mouse V1 that the induction of eTraces and their conversion to LTP/D by norepinephrine and serotonin respectively potentiates and depresses visual responses. We also show that the integrity of this process is crucial for ocular dominance plasticity, a canonical model of experience-dependent plasticity.

Indexed as

Long-Term PotentiationVisual CortexAnimalsMiceNeuronal PlasticityNorepinephrineSerotoninSynapsesNorepinephrineSerotonin

Identifiers

PMID35680879
PMCPMC9184610
OpenAlexW4282038391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.